![](https://cdn.georgeinstitute.org/sites/default/files/styles/width1920_fallback/public/main-images/stroke-1_0.jpg)
Phase III, minimally invasive surgery plus rt-PA in the treatment of intracerebral haemorrhage trial (MISTIE III)
An international clinical trial to determine the effectiveness of minimally invasive surgery plus intravenous rtPA (or alteplase) in patients with moderate-severe intracerebral haemorrhage (ICH).